Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

RECKITT PIRAMAL SETS Rs240 CRORE AS SALES TARGETS

Article Abstract:

Reckitt Piramal India Ltd (RPIL), a 60:40 joint venture between Reckitt & Coleman (R&C) and Nicholas Piramal India Ltd, has targeted sales of Rs240 crore for its first year of operations ending March 1999. The company plans to introduce six new products in 1999. The company's first product is likely to be Gaviscon, an anti-acidity drug. The media expenditure is to be met by both parties of the joint venture. R&C's Dettol, which commands 85 percent of the market segment faces growing competition from Hindustan Lever's Johnson & Johnson product Savlon which however, has just 10 percent of the market share. (nr)

Comment:

Reckitt Piramal India Ltd (RPIL), a 60:40 joint venture between Reckitt & Coleman (R&C) and Nicholas Piramal India Ltd, has targeted sales of Rs240 crore for its first year of operations ending March 1999.

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1998
Reckitt Piramal India Ltd

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


BURROUGHS WELLCOME SALES UP

Article Abstract:

Burroughs Wellcome India (BWI) has posted 8.4 percent rise in its sales to Rs203.16 crore for the year ended December 31, 1998 (Rs187.50 crore for 1997). During the period, the net profit grew by 38 percent to Rs24.90 crore (Rs18.03 crore). BWI incurred an expenditure of Rs2.04 crore (Rs0.83 crore) for voluntary retirement scheme. It proposes to pay 50 percent (40 percent) dividend. (ag)(psr)

Comment:

Burroughs Wellcome India (BWI) has posted 8.4 percent rise in its sales to Rs203.16 crore for the year ended December 31, 1998 (Rs187.50 crore for 1997).

Publisher: Bennett, Coleman & Co. Ltd.
Publication Name: Economic Times
Subject: Business, international
ISSN: 0013-0389
Year: 1999
Drugs, Burroughs Wellcome India

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Drugs, India
Similar abstracts:
  • Abstracts: IPCA LABORATORIES LIMITED ON A STRONG COMEBACK TRAIL - PARKE DAVIS INDIA LTD. JB CHEMICALS DECLARES 1:1 BONUS
  • Abstracts: LUPIN LABORATORIES LTD CIPLA TURBULENT TIMES
  • Abstracts: ANCO COMMUNICATIONS LIMITED HUGHES ISPAT PAYS UP Rs79 CR. PANEL FOR BREATHING LIFE INTO ITI, HTL
  • Abstracts: GINNI FILAMENTS LIMITED L&T SEES NEW THRUST AREAS
  • Abstracts: NATURAL CAPSULES LIMITED CHEMINOR DRUGS POSTS 416% RISE IN Q2 NET. A CHEMISTRY THAT WORKS: DR REDDY's LABS
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.